Pharmaceutical Research entered the industry of Commercial Medical Research in 1991 and has grown to employ 1 to 4 people, generating an annual revenue of $500.000 to $999.999. The NAICS classifies this business under the code 6219993, which describes it as a Commercial Medical Research. For further clarification, the SIC classifies this business under the code 8731 and described it as a Commercial Medical Research. The business provides service to the B2B market.
To acquire more information, please contact Gary Gross, Owner by calling (214) 361-5555 during business hours. You can also write to the business’ Single Location at 5499 Glen Lakes Drive # 200, Dallas, Texas TX 75231. You can also visit the company’s website at . View this business’ social media profiles on Twitter or on Facebbok .
Company: | Pharmaceutical Research |
Representative: | Gary Gross, Owner |
Place of Business: | 5499 Glen Lakes Drive # 200, Dallas, TX 75231 |
Contact Number: | (214) 361-5555 |
Type of Service: | Commercial Medical Research |
SIC Number: | 8731 |
NAICS Number: | 6219993 |
Locality: | Single Location |
Market Type: | B2B (Business to Business) |
Began: | 1991 |
Income/Year: | $500.000 to $999.999 |
Laborers: | 1 to 4 |
Share This Company: |
Pharmaceutical Research is a company operating from Dallas, Texas providing professional Commercial Medical Research and relevant B2B variables. It was founded in 1991 and registered with the SIC code 8731 as Commercial Medical Research, and with the NAICS code 6219993 as Commercial Medical Research.
With a current employee count of 1 to 4, Pharmaceutical Research has gone to report making $500.000 to $999.999 per annum on its journey towards growth. This company invites you to contact its representative Gary Gross, Owner at (214) 361-5555 for related queries, or to locate its Single Location using the coordinates 32.88341,-96.7657.
The Single Location can also be found at the street address 5499 Glen Lakes Drive # 200 in Dallas, Texas 75231 and can be engaged online through the company website at , the company Twitter , and Facebook page .